{"id":"W4310497577","doi":"10.1111/bcp.15622","title":"Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time‐varying clearance","year":2022,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Pharmacokinetics; Medicine; Tremelimumab; NONMEM; Dosing; Population; Durvalumab; Internal medicine; Volume of distribution; Pharmacology; Oncology; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003420959,0.0006646237,0.001222996,0.0003921754,0.0001584892,0.001241078,0.0007398253,0.000861297,0.001005561],"category_scores_gemma":[0.005352387,0.0004035767,0.002179604,0.0004208325,0.0002302752,0.0004967317,0.0004734735,0.000761917,0.0002918516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008038998,"about_ca_system_score_gemma":0.00115354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005852246,"about_ca_topic_score_gemma":0.002641071,"domain_scores_codex":[0.9991917,0.0004655696,0.00004158938,0.000161035,0.00008230435,0.00005778769],"domain_scores_gemma":[0.9981275,0.001278556,0.0003387675,0.00007726137,0.0001369372,0.00004094861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001568253,0.0001706238,0.0334534,0.0003416433,0.00201488,0.0004131677,0.0002018131,0.9335816,0.005208226,0.001290225,0.001046138,0.02070999],"study_design_scores_gemma":[0.0002148569,0.0007828551,0.01734767,0.00004495518,0.0006985988,0.0003099438,0.00005340276,0.9742461,0.001791968,0.001990799,0.002479901,0.00003892402],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8668708,0.003880851,0.1216671,0.0009533436,0.00004290776,0.0002884219,0.003113369,0.0003503514,0.002832955],"genre_scores_gemma":[0.9909314,0.0007112401,0.005828101,0.0001026328,0.00001516344,0.0002156152,0.00107897,0.00002300698,0.001093879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005852246,"threshold_uncertainty_score":0.01809198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02583676521146915,"score_gpt":0.3713896467757096,"score_spread":0.3455528815642404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}